Lincoln biotech company gets $20 million venture capital investment
By Matt Olberding, Lincoln Journal Star.
Bio Nebraska member, Adjuvance, gets $20 million venture capital investment. Read more
Bio Industry
Bio Nebraska in the latest issue of Midlands Business Journal
Our executive director, Rob Owen, talks about our organization, our members (including ProTransit Nanotherapy), and what we’ve been up to, like our Women in STEM initiative. Read more
Clinical trials mean $394 million boost to Nebraska’s economy, treatments for Nebraskans
By Julie Anderson Omaha World-Herald staff writer. Read more